Phlebotomy Dependent Polycythemia Vera

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Phlebotomy Dependent Polycythemia Vera trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

Active — Not RecruitingPhase 2

NCT05143957

A Study to Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia Vera

The main purpose of this study is to evaluate the efficacy of sapablursen in reducing the frequency of phlebotomy and in improving quality of life assessments i…

United States50 participantsStarted 2021-12-30

Treatment: sapablursen

UnknownPhase 2

NCT03669965

KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera

This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with phlebotomy-dependent polycythemia vera (PV). Inh…

United States20 participantsStarted 2019-01-15

Treatment: KRT-232, Ruxolitinib